SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-018906
Filing Date
2023-05-24
Accepted
2023-05-24 16:00:21
Documents
14
Period of Report
2023-05-22
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56365
2 ex4-2.htm EX-4.2 160494
3 ex4-3.htm EX-4.3 151774
  Complete submission text file 0001493152-23-018906.txt   609602

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mrzm-20230522.xsd EX-101.SCH 3227
5 XBRL LABEL FILE mrzm-20230522_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mrzm-20230522_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3390
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 23954025
SIC: 2834 Pharmaceutical Preparations